Edition:
United States

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

0.51USD
21 Jun 2018
Change (% chg)

-- (--)
Prev Close
$0.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
290,674
52-wk High
$2.83
52-wk Low
$0.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.56 -0.336
FY 2017 Dec '17 0.14 -0.611
Sep '17 0.11 -0.707
Jun '17 0.32 -0.287
Mar '17 0.21 -1.232
FY 2016 Dec '16 0.17 -0.804
Sep '16 1.65 -0.294
Jun '16 2.25 -1.964
Mar '16 1.47 -2.650
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.22 0.52 0.00 --
Quarter Ending Sep-18 3 0.67 1.87 0.00 --
Year Ending Dec-18 3 2.18 5.00 0.56 0.78
Year Ending Dec-19 3 3.22 8.50 0.00 22.97
Earnings (per share)
Quarter Ending Jun-18 3 -0.08 -0.07 -0.08 --
Quarter Ending Sep-18 3 -0.08 -0.06 -0.10 --
Year Ending Dec-18 2 -0.47 -0.39 -0.54 -2.73
Year Ending Dec-19 3 -0.31 -0.28 -0.34 -2.85
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.56 34.04
P/E High - Last 5 Yrs. -- 41.92 47.73
P/E Low - Last 5 Yrs. -- 23.75 25.07
Beta 0.58 0.79 0.78
Price to Sales (TTM) 36.49 3.62 8.22
Price to Book (MRQ) -- 3.72 4.29
Price to Tangible Book (MRQ) -- 4.64 6.00
Price to Cash Flow (TTM) -- 20.03 22.60
% Owned Institutions 9.23 1.29 2.44

Dividends

  Company industry sector
Dividend Yield -- 1.84 1.70
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- -9.36 -6.32
Payout Ratio(TTM) -- 43.13 40.51

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 168.57 4.42 5.40
Sales (TTM) vs TTM 1 Yr. Ago -73.35 10.71 12.76
Sales - 5 Yr. Growth Rate -55.71 7.14 7.90
EPS (MRQ) vs Qtr. 1 Yr. Ago 72.70 45.92 41.23
EPS (TTM) vs TTM 1 Yr. Ago 54.79 -- --
EPS - 5 Yr. Growth Rate -- 6.41 8.05
Capital Spending - 5 Yr. Growth Rate -- 6.68 7.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.58 2.55
Current Ratio (MRQ) 0.81 3.67 3.62
LT Debt to Equity (MRQ) -- 10.64 13.12
Total Debt to Equity (MRQ) -- 14.79 17.61
Interest Coverage (TTM) -- 41.15 36.53

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.40 55.04
Gross Margin - 5 Yr. Avg. -- 52.83 52.94
EBITD Margin (TTM) -2,170.55 -- --
EBITD - 5 Yr. Avg -848.96 18.49 15.76
Operating Margin (TTM) -2,177.65 14.34 -0.32
Operating Margin - 5 Yr. Avg. -854.16 14.19 10.97
Pre-Tax Margin (TTM) -1,825.50 14.61 1.62
Pre-Tax Margin - 5 Yr. Avg. -829.56 14.41 11.14
Net Profit Margin (TTM) -1,836.72 11.21 -1.66
Net Profit Margin - 5 Yr. Avg. -832.18 10.74 7.49
Effective Tax Rate (TTM) -- 21.60 29.83
Effective Tax Rate - 5 Yr. Avg. -- 23.68 24.14

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,640 839,795,823 728,113,809
Net Income/Employee (TTM) -838,280 97,573,383 84,561,813
Receivable Turnover (TTM) 3.78 5.92 6.05
Inventory Turnover (TTM) -- 2.57 3.66
Asset Turnover (TTM) 0.09 0.90 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -166.53 10.80 10.33
Return on Assets - 5 Yr. Avg. -79.75 11.58 11.01
Return on Investment (TTM) -1,363.50 13.58 13.11
Return on Investment - 5 Yr. Avg. -105.51 15.02 14.30
Return on Equity (TTM) -- 15.39 15.11
Return on Equity - 5 Yr. Avg. -604.87 16.25 15.65
  1 Year 3 Year 5 Year
Sales % -85.81 -0.54 -55.71
EPS (TTM) % 39.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Onconova Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.82%
# of Holders: 28
Total Shares Held: 26,750,370
3 Mo. Net Change: 21,985,205
# New Positions: 9
# Closed Positions: 4
# Increased Positions: 16
# Reduced Positions: 5
# Net Buyers: 11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.